by clicking the arrows at the side of the page, or by using the toolbar.
by clicking anywhere on the page.
by dragging the page around when zoomed in.
by clicking anywhere on the page when zoomed in.
web sites or send emails by clicking on hyperlinks.
Bio Technology : July 2009
AusBioSTATES New South Wales AusBiotech would like to acknowledge the dedicated contribution of Mr Alan Liddle, CEO of Immune System Therapeutics Ltd, who recently stepped down from the Chair of the New South Wales Branch. Alan will continue his involvement with the Committee, having provided guidance and support as Chair for over a year. Dr David Irving, National Manager, Research and Business Development with the Australian Red Cross Blood Service has assumed the Chair of the New South Wales Branch. David has over 20 years’ experience in the life science sector, primarily in the biotechnology industry. Prior to joining ARCBS, David was the inaugural CEO of the Diabetes Vaccine Development Centre and was a founding Director of AusBiotech Limited. The NSW committees would also like to acknowledge Ms Vikki Hine, Manager, Investment & Industry Development with the Department of State & Regional Development. Vikki has provided energetic and enthusiastic support to the Committees of the NSW AusBiotech and NSW AusMedtech branches. Following a recent restructure of the Department of State Development, Vikki will now focus her efforts on the renewable energy and green technologies sector. AusMedtech Event – Managing the Manufacturing Process More than 30 guests attended the NSW AusMedtech ‘Managing the Manufacturing Process’ event, held at the National Innovation Centre in early May. Presentations explored the design process for high volume single use consumable devices, setting up manufacturing in low cost economies and developing IP for licensing opportunities Speakers at the event included Craig Wilson, VP Design OEM from ITL Design and Manufacturing, Bill Mobbs, former CEO and founder of ITL and Victor Skladnev, CEO of AiMedics Pty Ltd. The Speakers’ PowerPoint presentations are available on the AusBiotech website at www.ausbiotech.org. For information on NSW-based events and initiatives, please contact Nicole Brackenridge on 0435 019 685 or via email at firstname.lastname@example.org. Guests at the AusMedtech ‘Managing the Manufacturing Process’ event. The NSW Government, in collaboration with the universities of New South Wales and Macquarie have recently set aside considerable funds to establish a Science Industry Fund. This Fund is available to industry partners that would like to access any of the services provided by the five facilities under NCRIS 5.1 (Evolving Biomolecular Platforms and Informatics capability area) in New South Wales, being: • Australian Proteome Analysis Facility at Macquarie University; • The Ramaciotti Centre for Gene Function Analysis at UNSW; • Bioanalytical Mass Spectrometry Facility at UNSW; • The New South Wales Systems Biology Initiative at UNSW; • Centre for Plant Conservation Genetics at Southern Cross University. 56 Australasian BioTechnology Volume 19 • Number 2 • July 2009